These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 8686745)

  • 1. Evidence of neuronal oxidative damage in Alzheimer's disease.
    Good PF; Werner P; Hsu A; Olanow CW; Perl DP
    Am J Pathol; 1996 Jul; 149(1):21-8. PubMed ID: 8686745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread peroxynitrite-mediated damage in Alzheimer's disease.
    Smith MA; Richey Harris PL; Sayre LM; Beckman JS; Perry G
    J Neurosci; 1997 Apr; 17(8):2653-7. PubMed ID: 9092586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal DNA damage precedes tangle formation and is associated with up-regulation of nitrotyrosine in Alzheimer's disease brain.
    Su JH; Deng G; Cotman CW
    Brain Res; 1997 Nov; 774(1-2):193-9. PubMed ID: 9452208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein nitration in Parkinson's disease.
    Good PF; Hsu A; Werner P; Perl DP; Olanow CW
    J Neuropathol Exp Neurol; 1998 Apr; 57(4):338-42. PubMed ID: 9600227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress in Alzheimer's disease hippocampus: a topographical study.
    Cruz-Sánchez FF; Gironès X; Ortega A; Alameda F; Lafuente JV
    J Neurol Sci; 2010 Dec; 299(1-2):163-7. PubMed ID: 20863531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases.
    Aoyama K; Matsubara K; Fujikawa Y; Nagahiro Y; Shimizu K; Umegae N; Hayase N; Shiono H; Kobayashi S
    Ann Neurol; 2000 Apr; 47(4):524-7. PubMed ID: 10762167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of caspase-8 in the Alzheimer's disease brain.
    Rohn TT; Head E; Nesse WH; Cotman CW; Cribbs DH
    Neurobiol Dis; 2001 Dec; 8(6):1006-16. PubMed ID: 11741396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease.
    Gómez-Ramos P; Morán MA
    Microsc Res Tech; 1998 Oct; 43(1):49-58. PubMed ID: 9829459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial abnormalities in Alzheimer's disease.
    Hirai K; Aliev G; Nunomura A; Fujioka H; Russell RL; Atwood CS; Johnson AB; Kress Y; Vinters HV; Tabaton M; Shimohama S; Cash AD; Siedlak SL; Harris PL; Jones PK; Petersen RB; Perry G; Smith MA
    J Neurosci; 2001 May; 21(9):3017-23. PubMed ID: 11312286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropathological changes associated with normal brain aging.
    Hof PR; Glannakopoulos P; Bouras C
    Histol Histopathol; 1996 Oct; 11(4):1075-88. PubMed ID: 8930649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis.
    Beal MF; Ferrante RJ; Browne SE; Matthews RT; Kowall NW; Brown RH
    Ann Neurol; 1997 Oct; 42(4):644-54. PubMed ID: 9382477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of calcipressin1, an inhibitor of the phosphatase calcineurin, is altered with aging and Alzheimer's disease.
    Cook CN; Hejna MJ; Magnuson DJ; Lee JM
    J Alzheimers Dis; 2005 Sep; 8(1):63-73. PubMed ID: 16155351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibodies to a 100-kd protein reveal abundant A beta-negative plaques throughout gray matter of Alzheimer's disease brains.
    Schmidt ML; Lee VM; Forman M; Chiu TS; Trojanowski JQ
    Am J Pathol; 1997 Jul; 151(1):69-80. PubMed ID: 9212733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
    Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
    Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early accumulation of heparan sulfate in neurons and in the beta-amyloid protein-containing lesions of Alzheimer's disease and Down's syndrome.
    Snow AD; Mar H; Nochlin D; Sekiguchi RT; Kimata K; Koike Y; Wight TN
    Am J Pathol; 1990 Nov; 137(5):1253-70. PubMed ID: 2146882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: I. Superior frontal and inferior temporal cortex.
    Hof PR; Cox K; Morrison JH
    J Comp Neurol; 1990 Nov; 301(1):44-54. PubMed ID: 2127598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological correlates of extrapyramidal signs in Alzheimer's disease.
    Liu Y; Stern Y; Chun MR; Jacobs DM; Yau P; Goldman JE
    Ann Neurol; 1997 Mar; 41(3):368-74. PubMed ID: 9066358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.